Personalized brain MRI revealed distinct functional and anatomical disruptions in Creutzfeldt-Jakob disease and Alzheimer's disease

被引:1
作者
Guo, Yanjun [1 ]
Ren, Jianxun [2 ]
Cui, Weigang [3 ]
Dahmani, Louisa [4 ]
Wang, Danhong [4 ]
Fu, Xiaoxuan [2 ]
Li, Meiling [2 ]
Li, Shiyi [2 ]
Zhang, Yi [5 ]
Lin, Xue [1 ]
Zhen, Zhen [1 ]
Xu, Yichen [6 ]
Xie, Dan [7 ]
Guan, Hongzhi [8 ]
Yi, Fang [9 ]
Wang, Jiawei [1 ]
Shi, Qi [10 ]
Liu, Hesheng [2 ,11 ,12 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Neurol, Beijing, Peoples R China
[2] Changping Lab, Beijing, Peoples R China
[3] Beihang Univ, Sch Engn Med, Beijing, Peoples R China
[4] Harvard Med Sch, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA USA
[5] Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China
[6] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China
[7] Capital Med Univ, Beijing Friendship Hosp, Dept Neurol, Beijing, Peoples R China
[8] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China
[9] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Lishilu Outpatient, Beijing, Peoples R China
[10] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China
[11] Peking Univ, Biomed Pioneering Innovat Ctr, Beijing, Peoples R China
[12] Changping Lab, 28 Zhongguancun Life Sci Pk,Beiqing Rd, Beijing, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Alzheimer's disease; brain cortical thickness; Creutzfeldt-Jakob disease; fMRI; DIFFUSION-WEIGHTED MRI; ARCHITECTURE; SCALE; CJD;
D O I
10.1111/cns.14404
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
AimsCreutzfeldt-Jakob disease (CJD) is a lethal neurodegenerative disorder, which leads to a rapidly progressive dementia. This study aimed to examine the cortical alterations in CJD, changes in these brain characteristics over time, and the differences between CJD and Alzheimer's disease (AD) that show similar clinical manifestations. MethodsTo obtain reliable, subject-specific functional measures, we acquired 24 min of resting-state fMRI data from each subject. We applied an individual-based approach to characterize the functional brain organization of 10 patients with CJD, 8 matched patients with AD, and 8 normal controls. We measured cortical atrophy as well as disruption in resting-state functional connectivity (rsFC) and then investigated longitudinal brain changes in a subset of CJD patients. ResultsCJD was associated with widespread cortical thinning and weakened rsFC. Compared with AD, CJD showed distinct atrophy patterns and greater disruptions in rsFC. Moreover, the longitudinal data demonstrated that the progressive cortical thinning and disruption in rsFC mainly affected the association rather than the primary cortex in CJD. ConclusionsCJD shows unique anatomical and functional disruptions in the cerebral cortex, distinct from AD. Rapid progression of CJD affects both the cortical thickness and rsFC in the association cortex.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Iatrogenic Dementia: Providing Insight into Transmissible Subtype of Alzheimer's Disease, Creutzfeldt-Jakob Disease and Cerebral Amyloid Angiopathy
    Karatzetzou, Stella
    Ioannidis, Serafeim
    Konstantinopoulou, Eleni
    Parisis, Dimitrios
    Afrantou, Theodora
    Ioannidis, Panagiotis
    BIOMOLECULES, 2025, 15 (04)
  • [42] Reconfigured metabolism brain network in asymptomatic Creutzfeldt-Jakob disease
    Kong, Yu
    Chen, Zhongyun
    Zhang, Jing
    Wang, Yihao
    Chu, Min
    Nan, Haitian
    Cui, Yue
    Jiang, Deming
    Wu, Liyong
    NEUROBIOLOGY OF DISEASE, 2025, 206
  • [43] An atypical case of sporadic Creutzfeldt-Jakob disease with Parkinson's disease
    Iida, T
    Doh-ura, K
    Kawashima, T
    Abe, H
    Iwaki, T
    NEUROPATHOLOGY, 2001, 21 (04) : 294 - 297
  • [44] Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer’s disease
    Bart Van Everbroeck
    Itte Dobbeleir
    Michèle De Waele
    Evelyn De Leenheir
    Ursula Lübke
    Jean-Jacques Martin
    Patrick Cras
    Acta Neuropathologica, 2004, 108 : 194 - 200
  • [45] Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's disease
    Van Everbroeck, B
    Dobbeleir, I
    De Waele, M
    De Leenheir, E
    Lübke, U
    Martin, JJ
    Cras, P
    ACTA NEUROPATHOLOGICA, 2004, 108 (03) : 194 - 200
  • [46] EEG and Cranial MRI Findings in Heidenhain Variant of Creutzfeldt-Jakob Disease
    Guveli, Betul Tekin
    Oktar, Ayla Culha
    Cabalar, Murat
    Karamanli, Yasemin
    Yazar, Tamer
    Yayla, Vildan
    JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2014, 31 (01): : 218 - 223
  • [47] Creutzfeldt-Jakob disease: Serial changes on diffusion-weighted MRI
    Matoba, M
    Tonami, H
    Miyaji, H
    Yokota, H
    Yamamoto, I
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2001, 25 (02) : 274 - 277
  • [48] MRI in sporadic Creutzfeldt-Jakob disease: Correlation with clinical and neuropathological data
    Urbach, H
    Klisch, J
    Wolf, HK
    Brechtelsbauer, D
    Gass, S
    Solymosi, L
    NEURORADIOLOGY, 1998, 40 (02) : 65 - 70
  • [49] Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer’s Disease
    Saima Zafar
    Neelam Younas
    Susana Correia
    Mohsin Shafiq
    Waqas Tahir
    Matthias Schmitz
    Isidre Ferrer
    Olivier Andréoletti
    Inga Zerr
    Molecular Neurobiology, 2017, 54 : 697 - 709
  • [50] Alzheimer's disease biomarker utilization at first referral enhances differential diagnostic precision with simultaneous exclusion of Creutzfeldt-Jakob disease
    Wang, Zitianyu
    Lewis, Victoria
    Stehmann, Christiane
    Varghese, Shiji
    Senesi, Matteo
    Mcglade, Amelia
    Ellett, Laura J.
    Doecke, James D.
    Eratne, Dhamidhu
    Velakoulis, Dennis
    Masters, Colin L.
    Collins, Steven J.
    Li, Qiao-Xin
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2024, 16 (01)